Gene expression alterations in the cerebellum and granule neurons of Cstb-/- mouse are associated with early synaptic changes and inflammation

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Joensuu, Tarja ^a,b,c   Tegelberg, Saara ^a,b,c   Reinmaa, Eva ^a,f   Segerstråle, Mikael ^c   Hakala, Paula ^a,b,c   Pehkonen, Heidi ^d   Korpi, Esa R ^d   Tyynelä, Jaana ^c   Taira, Tomi ^c   Hovatta, Iiris ^c,e   Kopra, Outi ^a,b,c   Lehesjoki, Anna Elina ^a,b,c  

^a FOLKHÄLSAN INSTITUTE OF GENETICS   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^f UNIVERSITY OF TARTU   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; CYSTATIN B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBELLUM; CONTROLLED STUDY; CSTB GENE; FEMALE; GABAERGIC TRANSMISSION; GENE EXPRESSION REGULATION; GRANULE CELL; INHIBITION KINETICS; INTERNEURON; INTRACELLULAR SIGNALING; INTRACELLULAR TRANSPORT; LIGAND BINDING; MALE; MICROARRAY ANALYSIS; MYOCLONUS EPILEPSY; NERVE CELL PLASTICITY; NEUROPATHOLOGY; NONHUMAN; PERINATAL PERIOD; PHENOTYPIC VARIATION; PURKINJE CELL; UPREGULATION;

ANIMALS; ANIMALS, NEWBORN; CEREBELLUM; CYSTATIN B; DISEASE MODELS, ANIMAL; FEMALE; GABAERGIC NEURONS; GENE EXPRESSION REGULATION; LIGANDS; MALE; MICE; MICE, KNOCKOUT; MYOCLONIC EPILEPSIES, PROGRESSIVE; NEURONS; PROTEIN BINDING; PURKINJE CELLS; RECEPTORS, GABA-A; REPRODUCIBILITY OF RESULTS; SYNAPTIC POTENTIALS; TIME FACTORS;

EID: 84897879604     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089321     Document Type: Article

References (48)

1. Kälviäinen R, Khyuppenen J, Koskenkorva P, Eriksson K, Vanninen R, et al. (2008) Clinical picture of EPM1-Unverricht-Lundborg disease. Epilepsia 49: 549-556. (Pubitemid 351661066)
2. Lalioti MD, Scott HS, Buresi C, Rossier C, Bottani A, et al. (1997) Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy. Nature 386: 847-851. (Pubitemid 27181260)
3. Pennacchio LA, Lehesjoki AE, Stone NE, Willour VL, Virtaneva K, et al. (1996) Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 271: 1731-1734. (Pubitemid 26102822)
4. Pennacchio LA, Bouley DM, Higgins KM, Scott MP, Noebels JL, et al. (1998) Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice. Nat Genet 20: 251-258. (Pubitemid 28507669)
5. Lehtinen MK, Tegelberg S, Schipper H, Su H, Zukor H, et al. (2009) Cystatin B deficiency sensitizes neurons to oxidative stress in progressive myoclonus epilepsy, EPM1. J Neurosci 29: 5910-5915.
6. -/- mouse model of progressive myoclonus epilepsy, EPM1. J Neuropathol Exp Neurol 71: 40-53.
7. Rinne R, Saukko P, Järvinen M, Lehesjoki AE (2002) Reduced cystatin B activity correlates with enhanced cathepsin activity in progressive myoclonus epilepsy. Ann Med 34: 380-385. (Pubitemid 35351826)
8. Houseweart MK, Pennacchio LA, Vilaythong A, Peters C, Noebels JL, et al. (2003) Cathepsin B but not cathepsins L or S contributes to the pathogenesis of Unverricht-Lundborg progressive myoclonus epilepsy (EPM1). J Neurobiol 56: 315-327. (Pubitemid 37010940)
9. Kaur G, Mohan P, Pawlik M, DeRosa S, Fajiculay J, et al. (2010) Cystatin C rescues degenerating neurons in a cystatin B-knockout mouse model of progressive myoclonus epilepsy. Am J Pathol 177: 2256-2267.
10. Lieuallen K, Pennacchio LA, Park M, Myers RM, Lennon GG (2001) Cystatin B-deficient mice have increased expression of apoptosis and glial activation genes. Hum Mol Genet 10: 1867-1871. (Pubitemid 32910530)
11. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, et al. (1997) Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275: 661-665. (Pubitemid 27061332)
12. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
13. Zhang B, Kirov S, Snoddy J (2005) WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 33: W741-748. (Pubitemid 44530021)
14. Bible E, Gupta P, Hofmann SL, Cooper JD (2004) Regional and cellular neuropathology in the palmitoyl protein thioesterase-1 null mutant mouse model of infantile neuronal ceroid lipofuscinosis. Neurobiol Dis 16: 346-359. (Pubitemid 38757316)
15. Kielar C, Maddox L, Bible E, Pontikis CC, Macauley SL, et al. (2007) Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis. Neurobiol Dis 25: 150-162. (Pubitemid 44802811)
16. Gundersen HJ, Jensen EB (1987) The efficiency of systematic sampling in stereology and its prediction. J Microsc 147: 229-263.
17. Ippolito DM, Eroglu C (2010) Quantifying synapses: an immunocytochemistry-based assay to quantify synapse number. J Vis Exp.
18. Mäkelä R, Uusi-Oukari M, Homanics GE, Quinlan JJ, Firestone LL, et al. (1997) Cerebellar gamma-aminobutyric acid type A receptors: pharmacological subtypes revealed by mutant mouse lines. Mol Pharmacol 52: 380-388. (Pubitemid 27412962)
19. Uusi-Oukari M, Heikkilä J, Sinkkonen ST, Mäkelä R, Hauer B, et al. (2000) Long-range interactions in neuronal gene expression: evidence from gene targeting in the GABA(A) receptor beta2-alpha6-alpha1-gamma2 subunit gene cluster. Mol Cell Neurosci 16: 34-41. (Pubitemid 30616556)
20. Korpi ER, Kleingoor C, Kettenmann H, Seeburg PH (1993) Benzodiazepine-induced motor impairment linked to point mutation in cerebellar GABAA receptor. Nature 361: 356-359. (Pubitemid 23041628)
21. Manninen O, Koskenkorva P, Lehtimäki KK, Hyppönen J, Könönen M, et al. (2013) White matter degeneration with Unverricht-Lundborg progressive myoclonus epilepsy: a translational diffusion-tensor imaging study in patients and cystatin B-deficient mice. Radiology 269: 232-239.
22. Grusser-Cornehls U, Baurle J (2001) Mutant mice as a model for cerebellar ataxia. Prog Neurobiol 63: 489-540. (Pubitemid 32115431)
23. Ben-Ari Y (2006) Seizures beget seizures: the quest for GABA as a key player. Crit Rev Neurobiol 18: 135-144.
24. Briggs SW, Galanopoulou AS (2011) Altered GABA signaling in early life epilepsies. Neural Plast 2011: 527605.
25. Chiu C, Reid CA, Tan HO, Davies PJ, Single FN, et al. (2008) Developmental impact of a familial GABAA receptor epilepsy mutation. Ann Neurol 64: 284-293.
26. Hruska M, Dalva MB (2012) Ephrin regulation of synapse formation, function and plasticity. Mol Cell Neurosci 50: 35-44.
27. Jaworski A, Tessier-Lavigne M (2012) Autocrine/juxtaparacrine regulation of axon fasciculation by Slit-Robo signaling. Nat Neurosci 15: 367-369.
28. Borrell V, Cardenas A, Ciceri G, Galceran J, Flames N, et al. (2012) Slit/Robo signaling modulates the proliferation of central nervous system progenitors. Neuron 76: 338-352.
29. Marillat V, Cases O, Nguyen-Ba-Charvet KT, Tessier-Lavigne M, Sotelo C, et al. (2002) Spatiotemporal expression patterns of slit and robo genes in the rat brain. J Comp Neurol 442: 130-155.
30. Yagi T, Takeichi M (2000) Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. Genes Dev 14: 1169-1180. (Pubitemid 30327498)
31. Herrup K, Busser JC (1995) The induction of multiple cell cycle events precedes target-related neuronal death. Development 121: 2385-2395.
32. Kim AH, Puram SV, Bilimoria PM, Ikeuchi Y, Keough S, et al. (2009) A centrosomal Cdc20-APC pathway controls dendrite morphogenesis in postmitotic neurons. Cell 136: 322-336.
33. Yang Y, Kim AH, Yamada T, Wu B, Bilimoria PM, et al. (2009) A Cdc20-APC ubiquitin signaling pathway regulates presynaptic differentiation. Science 326: 575-578.
34. Becker EB, Bonni A (2005) Beyond proliferation-cell cycle control of neuronal survival and differentiation in the developing mammalian brain. Semin Cell Dev Biol 16: 439-448.
35. Alakurtti K, Weber E, Rinne R, Theil G, de Haan GJ, et al. (2005) Loss of lysosomal association of cystatin B proteins representing progressive myoclonus epilepsy, EPM1, mutations. Eur J Hum Genet 13: 208-215. (Pubitemid 40220566)
36. Riccio M, Di Giaimo R, Pianetti S, Palmieri PP, Melli M, et al. (2001) Nuclear localization of cystatin B, the cathepsin inhibitor implicated in myoclonus epilepsy (EPM1). Exp Cell Res 262: 84-94. (Pubitemid 32980247)
37. Ceru S, Konjar S, Maher K, Repnik U, Krizaj I, et al. (2010) Stefin B interacts with histones and cathepsin L in the nucleus. J Biol Chem 285: 10078-10086.
38. Graber S, Maiti S, Halpain S (2004) Cathepsin B-like proteolysis and MARCKS degradation in sub-lethal NMDA-induced collapse of dendritic spines. Neuropharmacology 47: 706-713. (Pubitemid 39348952)
39. Ludwig A, Li H, Saarma M, Kaila K, Rivera C (2003) Developmental upregulation of KCC2 in the absence of GABAergic and glutamatergic transmission. Eur J Neurosci 18: 3199-3206. (Pubitemid 38031046)
40. Hirokawa N, Niwa S, Tanaka Y (2010) Molecular motors in neurons: transport mechanisms and roles in brain function, development, and disease. Neuron 68: 610-638.
41. Chen Y, Du XY (2007) Functional properties and intracellular signaling of CCN1/Cyr61. J Cell Biochem 100: 1337-1345. (Pubitemid 46515568)
42. Gerke V, Creutz CE, Moss SE (2005) Annexins: linking Ca2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol 6: 449-461. (Pubitemid 40780557)
43. Twelvetrees AE, Yuen EY, Arancibia-Carcamo IL, MacAskill AF, Rostaing P, et al. (2010) Delivery of GABAARs to synapses is mediated by HAP1-KIF5 and disrupted by mutant huntingtin. Neuron 65: 53-65.
44. Yeger H, Perbal B (2007) The CCN family of genes: a perspective on CCN biology and therapeutic potential. J Cell Commun Signal 1: 159-164.
45. Farrant M, Nusser Z (2005) Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nat Rev Neurosci 6: 215-229. (Pubitemid 40342416)
46. Chandra D, Halonen LM, Linden AM, Procaccini C, Hellsten K, et al. (2010) Prototypic GABA(A) receptor agonist muscimol acts preferentially through forebrain high-affinity binding sites. Neuropsychopharmacology 35: 999-1007.
47. Buzzi A, Chikhladze M, Falcicchia C, Paradiso B, Lanza G, et al. (2012) Loss of cortical GABA terminals in Unverricht-Lundborg disease. Neurobiol Dis 47: 216-224.
48. Devinsky O, Vezzani A, Najjar S, De Lanerolle NC, Rogawski MA (2013) Glia and epilepsy: excitability and inflammation. Trends Neurosci 36: 174-184.